NASDAQ: SKYE
Skye Bioscience Inc Stock Ownership - Who owns Skye Bioscience?

Insider buying vs selling

Have Skye Bioscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
5am Partners VII LLC10% Owner2025-08-22163,979$3.42
$560.81kSell
5am Partners VII LLC10% Owner2025-08-226,470$3.42
$22.13kSell
Andrew J. SchwabDirector2025-08-22163,979$3.42
$560.81kSell
Andrew J. SchwabDirector2025-08-226,470$3.42
$22.13kSell
Andrew J. SchwabDirector2025-08-2158,642$3.57
$209.35kSell
5am Partners VII LLC10% Owner2025-08-212,314$3.57
$8.26kSell
5am Partners VII LLC10% Owner2025-08-2158,642$3.57
$209.35kSell
Andrew J. SchwabDirector2025-08-212,314$3.57
$8.26kSell

1 of 1

SKYE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SKYE insiders and whales buy or sell their stock.

SKYE Shareholders

What type of owners hold Skye Bioscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Versant Ventures III LLC1,428.21%501,925,802$395.02MInsider
Emerald Health Sciences Inc482.04%169,407,901$133.32MInsider
Andrew J. Schwab27.55%9,681,763$7.62MInsider
5am Partners VII LLC27.55%9,681,763$7.62MInsider
5am Venture Management LLC27.55%9,681,763$7.62MInstitution
Cosmas N. Lykos13.09%4,599,400$3.62MInsider
Reg Alexander Lapham10.78%3,787,500$2.98MInsider
Versant Venture Management LLC5.71%2,007,704$1.58MInstitution
Baker Bros Advisors LP4.48%1,575,243$1.24MInstitution
Richard D. Squires4.27%1,500,000$1.18MInsider

1 of 3

SKYE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SKYE2.23%97.77%Net Selling
PLUR0.02%99.98%Net BuyingNet Buying
TVRD8.05%91.95%
LGVN7.32%59.27%Net SellingNet Selling
LITS17.31%54.47%Net Selling

Skye Bioscience Stock Ownership FAQ

Who owns Skye Bioscience?

Skye Bioscience (NASDAQ: SKYE) is owned by 45.90% institutional shareholders, 2,014.13% Skye Bioscience insiders, and 0.00% retail investors. Versant Ventures III LLC is the largest individual Skye Bioscience shareholder, owning 501.93M shares representing 1,428.21% of the company. Versant Ventures III LLC's Skye Bioscience shares are currently valued at $366.41M.

If you're new to stock investing, here's how to buy Skye Bioscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.